Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

导出原文传递

翻译打印收藏纠错

作者： Ganugula R. ^[1] ; Nuthalapati N.K. ^[2] ; Dwivedi S. ^[3] ; Zou D. ^[4] ; Arora M. ; Friend R. ; Sheikh-Hamad D. ; Basu R. ; Kumar M.N.V.R.

作者单位： The Center for Convergent Bioscience and Medicine (CCBM) The University of Alabama ^[1] College of Community Health Sciences The University of Alabama ^[2] Division of Nephrology and Selzman Institute for Kidney Health Department of Medicine Baylor College of Medicine ^[3] Division of Endocrinology Center of Diabetes Technology University of Virginia School of Medicine ^[4]

关键词 Bioavailability Combination therapy Curcumin Diabetic kidney disease Inflammasome Insulin Oral delivery P38(MAPK)/P53 signaling axis

发布时间 2023-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Controlled Release

2023年353卷

621-633页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

Journal of Controlled Release

相似文献

Journal of Controlled Release

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

Journal of Controlled Release

相似文献

Journal of Controlled Release

相关期刊

检索历史清除